Market Indices


Latest News

David Grossman from Stifel Nicolaus issued a price target of $13.00...

July 16, 2026   INFY -0.09%

Thomas Chong from Jefferies issued a price target of $17.00 for...

July 16, 2026   KC 3.08%

from Barclays issued a price target of $15.00 for

July 16, 2026   XPEV 3.14%

from Barclays issued a price target of $15.50 for

July 16, 2026   VIV -0.71%

from Wells Fargo issued a price target of $2,500.00 for...

July 16, 2026   ASML 2.23%


Price Targets

David Grossman from Stifel Nicolaus issued a price target of $13.00 for INFY on 2026-07-16 10:41:49.The adjusted price target was set to $13.00.At the time of the announcement,

July 16, 2026   INFY -0.09%

Thomas Chong from Jefferies issued a price target of $17.00 for KC on 2026-07-16 10:37:48.The adjusted price target was set to $17.00.At the time of the announcement, KC...

July 16, 2026   KC 3.08%

from Barclays issued a price target of $15.00 for XPEV on 2026-07-16 10:25:22.The adjusted price target was set to $15.00.At the time of the announcement, XPEV was...

July 16, 2026   XPEV 3.14%

from Barclays issued a price target of $15.50 for VIV on 2026-07-16 10:21:08.The adjusted price target was set to $15.50.At the time of the announcement, VIV was...

July 16, 2026   VIV -0.71%

from Wells Fargo issued a price target of $2,500.00 for ASML on 2026-07-16 10:15:27.The adjusted price target was set to $2,500.00.At the time of the announcement, ASML...

July 16, 2026   ASML 2.23%



Market Movers

Top Gainers (%)
SY
So-Young International In
1.84
10.18%
MNSO
MINISO Group Holding Limi
12.62
9.45%
MESO
Mesoblast Limited
18.24
8.96%
NA
Nano Labs Ltd
1.98
8.39%
YJ
Yunji Inc.
1.43
7.52%
QH
Quhuo Limited
6.48
7.46%
SLN
Silence Therapeutics plc
10.45
7.18%
ADXN
Addex Therapeutics Ltd
6.19
6.72%

Annual/Quarterly Reports Summary

In a landscape marked by financial fluctuations, the company reported a rise in other income but faced significant operating expenses, leading to a net loss. Management is focused on building...

May 1, 2025   SMMT -2.59%

In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...

February 5, 2025   TEVA -0.82%

In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...

January 27, 2025   TEVA -0.82%